Relias Learning | RN Pharmacology A Comprehensive Examination
Relias RN Pharmacology A Comprehensive
Examination 2026/2027 | Verified
Questions
Relias Learning | RN Pharmacology A Comprehensive Examination | Professional Nursing Candidates
75 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Relias Learning | RN Pharmacology A Comprehensive Examination
Comprehensive Competency Examination Actual Exam | Academic Year 2026/2027
Relias RN Pharmacology A Comprehensive Examination 2026/2027 | Verified Questions
,INTRODUCTION
This comprehensive examination contains exactly 75 verified questions designed to reinforce the official Relias
Learning RN Pharmacology A course objectives for actual exam readiness and clinical proficiency, aligned to the
2026/2027 academic year. The questions are distributed across four core domains: Domain 1 – Pharmacokinetics
and Pharmacodynamics (19 questions); Domain 2 – Medication Administration and Safety (19 questions);
Domain 3 – Cardiovascular and Respiratory Pharmacology (19 questions); and Domain 4 – Neurologic,
Psychiatric, and Pain Management Pharmacology (18 questions). All content is original and constructed to
support professional-level mastery of pharmacologic principles, safe medication administration, and evidence-
based clinical decision-making as presented in the Relias RN Pharmacology A curriculum and foundational
nursing pharmacology resources.
ACTUAL QUESTIONS
Domain 1: Pharmacokinetics and Pharmacodynamics
Question 1. Which process describes the movement of a drug from its site of administration into
the bloodstream?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: A
Rationale: Absorption is the pharmacokinetic process by which a drug enters the systemic circulation from its
administration site. The rate and extent of absorption determine onset of action and are influenced by route,
formulation, and patient factors as described in foundational pharmacology principles.
Question 2. A drug with a high first-pass effect is best administered by which route to achieve
reliable systemic levels?
A. Oral tablet
B. Oral solution
C. Intravenous or another parenteral route that bypasses the liver
D. Rectal suppository only
Correct Answer: C
Rationale: High first-pass metabolism means a large fraction of an orally administered drug is metabolized by
the liver before reaching systemic circulation. Parenteral routes avoid this effect and produce more predictable
plasma concentrations.
Question 3. What does the term 'half-life' of a drug represent?
A. The time required for the plasma concentration of the drug to decrease by 50 percent
B. The time required for the drug to reach peak effect
C. The duration of the drug's therapeutic action
D. The time needed for full elimination of the drug
Correct Answer: A
Rationale: Elimination half-life is the time required for the plasma concentration to fall by one-half. It guides
dosing interval decisions and estimates the time needed to reach steady state or to clear the drug after
discontinuation.
Question 4. Which pharmacokinetic parameter primarily determines the loading dose of a drug?
A. Clearance
B. Half-life
C. Bioavailability
D. Volume of distribution
Correct Answer: D
Relias RN Pharmacology A Comprehensive Examination 2026/2027 | Verified Questions
, Rationale: Loading dose is calculated from the desired plasma concentration and the volume of distribution
(and bioavailability for extravascular routes). Volume of distribution reflects the extent to which the drug
disperses into tissues versus remaining in plasma.
Question 5. A patient with hepatic impairment is receiving a drug that undergoes extensive
hepatic metabolism. What change in dosing is most appropriate?
A. Reduce the dose or extend the dosing interval to avoid accumulation
B. Increase the dose to compensate for reduced metabolism
C. Switch exclusively to an oral formulation
D. No adjustment is needed because the kidneys will compensate
Correct Answer: A
Rationale: Hepatic impairment reduces the clearance of hepatically metabolized drugs, raising the risk of
accumulation and toxicity. Dose reduction or prolonged intervals are the standard adjustment based on
pharmacokinetic principles.
Question 6. What is the primary site of drug metabolism for most medications?
A. The kidneys
B. The lungs
C. The liver
D. The gastrointestinal lumen exclusively
Correct Answer: C
Rationale: The liver contains the highest concentration of drug-metabolizing enzymes, particularly the
cytochrome P450 system, making it the principal organ of biotransformation for the majority of medications.
Question 7. Which statement best describes a drug agonist?
A. A drug that binds to a receptor and produces a maximal or near-maximal response
B. A drug that binds to a receptor but produces no response
C. A drug that only blocks receptor activation
D. A drug that is inactive until metabolized
Correct Answer: A
Rationale: An agonist binds to and activates a receptor, producing a pharmacologic effect. Full agonists can
elicit the maximal tissue response; partial agonists produce a submaximal response even at full receptor
occupancy.
Question 8. What is the clinical significance of a narrow therapeutic index?
A. The drug may be given without monitoring
B. Small differences in dose or blood concentration may lead to serious therapeutic failures or adverse effects
C. The drug has no adverse effects
D. The drug is always administered as a single dose
Correct Answer: C
Rationale: Drugs with a narrow therapeutic index have a small margin between effective and toxic
concentrations. Careful dosing, monitoring of plasma levels when indicated, and patient education are required
to maintain safety.
Question 9. Protein binding primarily affects which pharmacokinetic process?
A. Distribution and the amount of free drug available to act at receptors
B. Absorption from the gastrointestinal tract only
C. Renal glomerular filtration exclusively
D. First-pass metabolism in the gut wall
Correct Answer: A
Rationale: Only unbound (free) drug can leave the vascular space, distribute to tissues, and bind to receptors.
Highly protein-bound drugs may have altered free fractions in states of hypoalbuminemia or when displaced by
other highly bound agents.
Relias RN Pharmacology A Comprehensive Examination 2026/2027 | Verified Questions
Relias RN Pharmacology A Comprehensive
Examination 2026/2027 | Verified
Questions
Relias Learning | RN Pharmacology A Comprehensive Examination | Professional Nursing Candidates
75 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Relias Learning | RN Pharmacology A Comprehensive Examination
Comprehensive Competency Examination Actual Exam | Academic Year 2026/2027
Relias RN Pharmacology A Comprehensive Examination 2026/2027 | Verified Questions
,INTRODUCTION
This comprehensive examination contains exactly 75 verified questions designed to reinforce the official Relias
Learning RN Pharmacology A course objectives for actual exam readiness and clinical proficiency, aligned to the
2026/2027 academic year. The questions are distributed across four core domains: Domain 1 – Pharmacokinetics
and Pharmacodynamics (19 questions); Domain 2 – Medication Administration and Safety (19 questions);
Domain 3 – Cardiovascular and Respiratory Pharmacology (19 questions); and Domain 4 – Neurologic,
Psychiatric, and Pain Management Pharmacology (18 questions). All content is original and constructed to
support professional-level mastery of pharmacologic principles, safe medication administration, and evidence-
based clinical decision-making as presented in the Relias RN Pharmacology A curriculum and foundational
nursing pharmacology resources.
ACTUAL QUESTIONS
Domain 1: Pharmacokinetics and Pharmacodynamics
Question 1. Which process describes the movement of a drug from its site of administration into
the bloodstream?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: A
Rationale: Absorption is the pharmacokinetic process by which a drug enters the systemic circulation from its
administration site. The rate and extent of absorption determine onset of action and are influenced by route,
formulation, and patient factors as described in foundational pharmacology principles.
Question 2. A drug with a high first-pass effect is best administered by which route to achieve
reliable systemic levels?
A. Oral tablet
B. Oral solution
C. Intravenous or another parenteral route that bypasses the liver
D. Rectal suppository only
Correct Answer: C
Rationale: High first-pass metabolism means a large fraction of an orally administered drug is metabolized by
the liver before reaching systemic circulation. Parenteral routes avoid this effect and produce more predictable
plasma concentrations.
Question 3. What does the term 'half-life' of a drug represent?
A. The time required for the plasma concentration of the drug to decrease by 50 percent
B. The time required for the drug to reach peak effect
C. The duration of the drug's therapeutic action
D. The time needed for full elimination of the drug
Correct Answer: A
Rationale: Elimination half-life is the time required for the plasma concentration to fall by one-half. It guides
dosing interval decisions and estimates the time needed to reach steady state or to clear the drug after
discontinuation.
Question 4. Which pharmacokinetic parameter primarily determines the loading dose of a drug?
A. Clearance
B. Half-life
C. Bioavailability
D. Volume of distribution
Correct Answer: D
Relias RN Pharmacology A Comprehensive Examination 2026/2027 | Verified Questions
, Rationale: Loading dose is calculated from the desired plasma concentration and the volume of distribution
(and bioavailability for extravascular routes). Volume of distribution reflects the extent to which the drug
disperses into tissues versus remaining in plasma.
Question 5. A patient with hepatic impairment is receiving a drug that undergoes extensive
hepatic metabolism. What change in dosing is most appropriate?
A. Reduce the dose or extend the dosing interval to avoid accumulation
B. Increase the dose to compensate for reduced metabolism
C. Switch exclusively to an oral formulation
D. No adjustment is needed because the kidneys will compensate
Correct Answer: A
Rationale: Hepatic impairment reduces the clearance of hepatically metabolized drugs, raising the risk of
accumulation and toxicity. Dose reduction or prolonged intervals are the standard adjustment based on
pharmacokinetic principles.
Question 6. What is the primary site of drug metabolism for most medications?
A. The kidneys
B. The lungs
C. The liver
D. The gastrointestinal lumen exclusively
Correct Answer: C
Rationale: The liver contains the highest concentration of drug-metabolizing enzymes, particularly the
cytochrome P450 system, making it the principal organ of biotransformation for the majority of medications.
Question 7. Which statement best describes a drug agonist?
A. A drug that binds to a receptor and produces a maximal or near-maximal response
B. A drug that binds to a receptor but produces no response
C. A drug that only blocks receptor activation
D. A drug that is inactive until metabolized
Correct Answer: A
Rationale: An agonist binds to and activates a receptor, producing a pharmacologic effect. Full agonists can
elicit the maximal tissue response; partial agonists produce a submaximal response even at full receptor
occupancy.
Question 8. What is the clinical significance of a narrow therapeutic index?
A. The drug may be given without monitoring
B. Small differences in dose or blood concentration may lead to serious therapeutic failures or adverse effects
C. The drug has no adverse effects
D. The drug is always administered as a single dose
Correct Answer: C
Rationale: Drugs with a narrow therapeutic index have a small margin between effective and toxic
concentrations. Careful dosing, monitoring of plasma levels when indicated, and patient education are required
to maintain safety.
Question 9. Protein binding primarily affects which pharmacokinetic process?
A. Distribution and the amount of free drug available to act at receptors
B. Absorption from the gastrointestinal tract only
C. Renal glomerular filtration exclusively
D. First-pass metabolism in the gut wall
Correct Answer: A
Rationale: Only unbound (free) drug can leave the vascular space, distribute to tissues, and bind to receptors.
Highly protein-bound drugs may have altered free fractions in states of hypoalbuminemia or when displaced by
other highly bound agents.
Relias RN Pharmacology A Comprehensive Examination 2026/2027 | Verified Questions
